SCHEMBL20299501

SCHEMBL20299501

O=C1C(=Cc2ccc(-c3ccccc3)cc2)C(=O)c2ccccc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.56
SIRT2 Q8IXJ6 1/20 0.54
SIRT1 Q96EB6 1/20 0.54
SIRT3 Q9NTG7 1/20 0.54
SIRT5 Q9NXA8 1/20 0.54
PTPN1 P18031 1/20 0.52
MAPT P10636 5/20 0.51
KMT2A Q03164 5/20 0.51
MEN1 O00255 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
HPGD P15428 1/20 0.51
CDC25A P30304 1/20 0.51
CDC25B P30305 1/20 0.51
CTDSP1 Q9GZU7 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
APP P05067 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
APAF1 O14727 1/20 0.50
NPC1 O15118 1/20 0.50
LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12334403 0.90 LCK (0.47) LCKSIRT2SIRT1SIRT3SIRT5
SCHEMBL22625286 0.89 LCK (0.66) LCKMAPTKMT2AMEN1L3MBTL1
SCHEMBL677432 0.87 MAPT (0.62) LCKMAPTKMT2AMEN1L3MBTL1
SCHEMBL10134130 0.83 CSNK2A2 (0.49) LCKSIRT2SIRT1SIRT3SIRT5
SCHEMBL25165798 0.82 LCK (0.50) LCKMAPTKMT2AMEN1L3MBTL1
SCHEMBL1225662 0.81 CYP19A1 (0.57) SIRT2SIRT1SIRT3SIRT5MAPT
SCHEMBL26172921 0.81 APP (0.55) LCKMAPTKMT2AMEN1L3MBTL1
SCHEMBL25165754 0.80 LCK (0.49) LCKMAPTKMT2AMEN1L3MBTL1
SCHEMBL3372898 0.80 LCK (0.56) LCKSIRT1MAPTKMT2AMEN1
SCHEMBL22625287 0.80 CSNK2A2 (0.59) LCKMAPTKMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018114965-A1 CLPX INHIBITORY COMPOUNDS FOR THE TREATMENT OF MULTI RESISTANT STAPHYLOCOCCUS AUREUS VIRULENCE AND FOR THE TREATMENT OF LEUKEMIA Technische Universität München (DE) 2018-06-28 WO disclosed